Carcinoma News and Research

RSS

Carcinoma is cancer that begins in the skin or in tissues that line or cover internal organs.

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Exelixis, Inc. today announced that the National Comprehensive Cancer Network updated its Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets.

7 Sep 2018

Endocrine Society announces winners of prestigious 2019 Laureate Awards

The Endocrine Society today announced it has chosen 13 leading endocrinologists as winners of its prestigious 2019 Laureate Awards, the top honors in the field.

6 Sep 2018

Tipping the scales to initiate tumorigenesis in the colon

The regulatory protein c-MYC plays an important role in promoting the development of many types of tumors. c-MYC is a transcription factor that controls the activity of large numbers of genes involved in cell division, and its overexpression leads to excessive cell proliferation.

5 Sep 2018

Novel approaches for personalized risk prognosis and individualized treatment of NAFLD

More and more adults - but also about 34 percent of obese children - suffer from non-alcoholic fatty liver disease. An unhealthy lifestyle with little physical activity and a diet high in fat, sugar and fructose and/or a genetic predisposition can be the underlying caus.

31 Aug 2018

All MSP participants with invasive breast cancer can undergo more sparing surgical treatment

Participants in the German mammography screening program (MSP) who have invasive breast cancer—including interval cancers—can on the whole undergo more sparing surgical treatment compared with non-participants.

31 Aug 2018

Novel approach reveals metabolic vulnerabilities in kidney cancer

In order to halt the growth of cancer cells, you have to know what feeds them. Researchers at the nationally recognized Kidney Cancer Program at UT Southwestern's Harold C. Simmons Comprehensive Cancer Center have developed a novel approach using glucose that may open up new opportunities for therapeutic intervention.

30 Aug 2018

Study yields therapeutic clues to combat drug resistance in rare aggressive cancer

Stephen Elledge, PhD, and his team did not set out to find therapies that could render tumors less resistant to therapy or make existing drugs more potent against a rare form of cancer. But these are precisely the clinical insights that their most recent study has yielded.

29 Aug 2018

Researchers discover mechanism that steers growth of cancer cells in melanoma and liver cancer

Melanoma and liver cancer are becoming more widespread in Europe and the US. Whilst both diseases progress very differently, they are among the types of cancer which are most likely to be fatal in the Western world.

29 Aug 2018

Study suggests new strategies for using cell metabolism to treat cancer

Researchers at the University of Cincinnati College of Medicine have discovered that cell metabolism plays an important role in the ability of cells to start a survival program called autophagy, an unwanted side effect of some anti-cancer drugs that helps some tumor cells dodge treatment and eventually regrow into new tumors.

29 Aug 2018

New approach to assess kidney tumors could prevent patients from undergoing unnecessary surgery

A research team from Roswell Park Comprehensive Cancer Center has discovered a way to use computed tomography imaging to assess kidney tumors that test positive for the biomarker CD117 and accurately determine before surgery, whether the tumor is benign or malignant.

29 Aug 2018

Researchers develop new way to detect cancer cells in the blood using malaria protein

Cancer tumor cells in the blood can be more accurately and cheaply detected using a malaria protein, new research led by UNSW’s Chris Heeschen shows.

28 Aug 2018

Immune-related enzymes cause aggressive skin cancer in patients with Butterfly Syndrome

Patients with a rare skin disease, commonly called Butterfly Syndrome, that causes chronic blistering and extensive scarring also develop an aggressive and fatal form of cancer early in life.

28 Aug 2018

Research solves mystery on nature of EGFR signaling and how it drives development

What do cancer and the growing legs of a fruit fly have in common? They can both be influenced by a single molecule, a protein that tends to call the shots inside of embryos as they develop into living, breathing animals.

28 Aug 2018

Forbius receives $18.75 million grant from CPRIT for Phase 2a development of AVID100

Forbius announced today that it has been awarded a Product Development grant totaling $18.75 million from the Cancer Prevention and Research Institute of Texas.

25 Aug 2018

Advanced microscopes determine structure of molecular complex implicated in several cancers

In a study published today in Science, UT Southwestern and Rockefeller University researchers used advanced microscopes to determine at atomic resolution the structure of a molecular complex implicated in birth defects and several cancers.

24 Aug 2018

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Eisai Co., Ltd. and Merck & Co., Inc., Kenilworth N.J., U.S.A., known as MSD outside of the United States and Canada, announced today that the European Commission has granted a marketing authorization for the oral receptor tyrosine kinase inhibitor LENVIMA (lenvatinib mesylate) as a single agent for the first-line treatment of adult patients with advanced or unresectable hepatocellular carcinoma who have received no prior systemic therapy.

23 Aug 2018

Carcinoma News and Research

Further Reading

NCCN updates Clinical Practice Guidelines to include new recommendations for CABOMETYX tablets

Endocrine Society announces winners of prestigious 2019 Laureate Awards

Tipping the scales to initiate tumorigenesis in the colon

Novel approaches for personalized risk prognosis and individualized treatment of NAFLD

All MSP participants with invasive breast cancer can undergo more sparing surgical treatment

Novel approach reveals metabolic vulnerabilities in kidney cancer

Study yields therapeutic clues to combat drug resistance in rare aggressive cancer

Researchers discover mechanism that steers growth of cancer cells in melanoma and liver cancer

Study suggests new strategies for using cell metabolism to treat cancer

New approach to assess kidney tumors could prevent patients from undergoing unnecessary surgery

Researchers develop new way to detect cancer cells in the blood using malaria protein

Immune-related enzymes cause aggressive skin cancer in patients with Butterfly Syndrome

Research solves mystery on nature of EGFR signaling and how it drives development

Forbius receives $18.75 million grant from CPRIT for Phase 2a development of AVID100

Advanced microscopes determine structure of molecular complex implicated in several cancers

Eisai: EC approves marketing of LENVIMA as first-line treatment for hepatocellular carcinoma

Discovery could lead to new targeted treatment for people with lung cancer

FDA approves Dako PD-L1 IHC 22C3 pharmDx assay for expanded use in urothelial carcinoma

Research explores relationship between personal history of infectious fever and cancer risk

Biomarker predicts kidney cancer risk years before diagnosis

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News